BTN3A1 and colorectal carcinoma: Furthermore, BTN3A1 is detected in CRC at the tumor site, on epithelial and stromal cells, often close to areas infiltrated by Vδ2 T lymphocytes, making conceivable the use of N-BPs in therapeutic schemes against CRC [19].